Piper Jaffray Downgrades Clovis Oncology, Asks 'Point Of Maximal Optimism?'

By: via Benzinga
In a report published Friday, Piper Jaffray analysts downgraded the rating on Clovis Oncology Inc (NASDAQ: CLVS) from Overweight to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.